Pharmaceutical

eCential Robotics Appoints Clément Vidal as New Chief Executive Officer

GIÈRES (GRENOBLE), France and NASHVILLE, Tenn., July 18, 2024 /PRNewswire/ -- eCential Robotics is pleased to announce the appointment of…

1 year ago

Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor

VANCOUVER, BC, July 18, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased…

1 year ago

Eyenuk Appoints Bryan Haardt as Chief Executive Officer

Haardt brings decades of digital healthcare experience to build on Eyenuk's global mission of using AI to detect and prevent…

1 year ago

K2 Laboratory Obtains NDC Codes for Two Investigational Drugs

K2 Laboratory recently announced that its two investigational drugs, Brain Rehabilitation oral solution and Telomerase Inhibitor oral solution, have successfully…

1 year ago

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer’s biosimilar to Humira®

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,…

1 year ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning

Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation…

1 year ago

Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility

Company poised to execute additional cGMP activities throughout the remainder of the yearDURHAM, N.C., July 18, 2024 (GLOBE NEWSWIRE) --…

1 year ago

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Nose-to-Brain Drug Delivery Shows Promising Patient Safety and Therapeutic Benefit The Device and CMC Development Master Plan is designed to…

1 year ago

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

VOQUEZNA is now approved and available to treat the largest category of Gastroesophageal Reflux Disease (GERD)VOQUEZNA met its primary endpoint…

1 year ago